Literature DB >> 17722742

Pediatric cancers in the new millennium: dramatic progress, new challenges.

Lisa M McGregor1, Monika L Metzger, Robert Sanders, Victor M Santana.   

Abstract

Over the past 50 years, great strides have been made in diagnosis, treatment, and survival of childhood cancer. In the 1960s the probability of survival for a child with cancer was less than 25%, whereas today it may exceed 80%. This dramatic change has occurred through significant and steady progress in our understanding of tumor biology, creation of specialized multidisciplinary care teams, incremental improvements in therapy, establishment of specialized centers with research infrastructure to conduct pivotal clinical studies, and the evolution of a cooperative group mechanism for clinical research. Most children with cancer in the United States, Europe, and Japan receive appropriate diagnosis and treatment, although access is limited in developing countries. The price of success, however, is the growing population of survivors who require medical and psychosocial follow-up and treatment for the late effects of therapy. Here we review the progress made in pediatric oncology over the past 3 decades and consider the new challenges that face us today.

Entities:  

Mesh:

Year:  2007        PMID: 17722742

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN: 0890-9091            Impact factor:   2.990


  17 in total

1.  Identification of potential serum biomarkers for Wilms tumor after excluding confounding effects of common systemic inflammatory factors.

Authors:  Jiaxiang Wang; Lei Wang; Da Zhang; Yuxia Fan; Zhankui Jia; Pan Qin; Jiekai Yu; Shu Zheng; Fuquan Yang
Journal:  Mol Biol Rep       Date:  2011-12-08       Impact factor: 2.316

Review 2.  Good clinical practice and the conduct of clinical studies in pediatric oncology.

Authors:  Susan Devine; Ramzi N Dagher; Karen D Weiss; Victor M Santana
Journal:  Pediatr Clin North Am       Date:  2008-02       Impact factor: 3.278

3.  Pediatric surgical oncology in China: present and future.

Authors:  Jin-Zhe Zhang
Journal:  World J Pediatr       Date:  2009-07-09       Impact factor: 2.764

4.  Identification of novel serum biomarkers in child nephroblastoma using proteomics technology.

Authors:  Qian Zhang; Jiaxiang Wang; Rui Dong; Shaobo Yang; Shu Zheng
Journal:  Mol Biol Rep       Date:  2010-04-06       Impact factor: 2.316

5.  A sustainable model for pediatric oncology nursing education in low-income countries.

Authors:  Sara W Day; Jose Garcia; Federico Antillon; Judith A Wilimas; Leslie M McKeon; Rita M Carty; Pedro de Alarcon; Ching-Hon Pui; Raul C Ribeiro; Scott C Howard
Journal:  Pediatr Blood Cancer       Date:  2011-11-18       Impact factor: 3.167

6.  Use of Joint Commission International standards to evaluate and improve pediatric oncology nursing care in Guatemala.

Authors:  Sara W Day; Leslie M McKeon; Jose Garcia; Judith A Wilimas; Rita M Carty; Pedro de Alarcon; Federico Antillon; Scott C Howard
Journal:  Pediatr Blood Cancer       Date:  2012-09-26       Impact factor: 3.167

7.  Indications for admission, treatment and improved outcome of paediatric haematology/oncology patients admitted to a tertiary paediatric ICU.

Authors:  C Owens; D Mannion; A O'Marcaigh; M Waldron; K Butler; A O'Meara
Journal:  Ir J Med Sci       Date:  2010-11-10       Impact factor: 1.568

8.  Promoting education, mentorship, and support for pediatric research.

Authors: 
Journal:  Pediatrics       Date:  2014-05       Impact factor: 7.124

9.  A cross-cultural perspective on challenges facing comparative cancer survivorship research.

Authors:  Astri Syse; Berta Geller
Journal:  J Cancer Epidemiol       Date:  2011-10-19

10.  Increasing and worsening late effects in childhood cancer survivors during follow-up.

Authors:  Jung Woo Han; Hyo Sun Kim; Beom Sik Kim; Seung Yeon Kwon; Yoon Jung Shin; Sun Hee Kim; Jong Hee Ko; Chuhl Joo Lyu
Journal:  J Korean Med Sci       Date:  2013-05-02       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.